EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021
Media advisory: The full article and editorial are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2021.3422?guestAccessKey=532f5276-da68-4f7e-9400-3f3f5b1f2c6f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421
Authors: Michael R. Irwin, M.D., of the David Geffen School of Medicine at UCLA in Los Angeles, is the corresponding author.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.